Skip to main content
Top
Published in: Obesity Surgery 2/2009

01-02-2009 | Research Article

Glucose Tolerance in the Proximal Versus the Distal Small Bowel in Wistar Rats

Authors: Marcus Vinicius Dantas de Campos Martins, Antônio Augusto Peixoto, Alberto Schanaider, Christiano Costa Esposito, Carolina Barreira Albano Aratanha

Published in: Obesity Surgery | Issue 2/2009

Login to get access

Abstract

Background

Type 2 diabetes is an epidemic and insulin resistance is the central etiology of this disease. Obesity increases insulin resistance and glucose intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes. Bariatric surgery is the most effective treatment for severe obesity. Most reported series show that return to euglycemia and normal insulin levels occur days after gastric bypass and biliopancreatic diversion, long before major weight loss has taken place. The mechanisms underlying this dramatic reversal of type 2 diabetes following these bariatric procedures are not well understood.

Methods

Twelve Wistar rats were fed with a palatable hyperlipidic diet for 12 weeks. Body weight, glucose, and intraperitoneal glucose tolerance test were measured regularly. On day 91, they were randomized in two groups (hindgut and controls) and operated. Twenty-one days later, the tests were done again and the hindgut group re-operated. A duodenal exclusion was done. The results of an intraperitoneal glucose tolerance test were compared after the procedures.

Results

Body weight increased regularly in all the rats. Some rats developed hyperglycemia 28 days after beginning hyperlipidic diet, but these levels returned to baseline on days 56 and 84. The glucose tolerance test showed an improvement in glycemic levels in the hindgut group 21 days after the first operation (151 ± 21mg/dl). After the second operation, despite weight loss, the glucose tolerance test of the foregut group worsened again (267 ± 53 mg/dl) (p < 0.01).

Conclusion

Comparing the “hindgut hypothesis” and the “foregut hypothesis”, our data show an improvement in the 30 min glucose tolerance test in the hindgut group.
Literature
1.
go back to reference Venkat Narayan KM, Gregg EW, Fagot-Campagna A, et al. Diabetes:a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000;50(Suppl 2):S77–84.CrossRef Venkat Narayan KM, Gregg EW, Fagot-Campagna A, et al. Diabetes:a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000;50(Suppl 2):S77–84.CrossRef
2.
go back to reference Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metabol Clin. 2003;32(4):805–22.CrossRef Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metabol Clin. 2003;32(4):805–22.CrossRef
3.
go back to reference Albu J, Pi-Sunyer FX. Obesity and diabetes. In: Bray GA, Bouchard C, James WPT, editors. Handbook of obesity. New York: Marcel Dekker; 1998. p. 697–707. Albu J, Pi-Sunyer FX. Obesity and diabetes. In: Bray GA, Bouchard C, James WPT, editors. Handbook of obesity. New York: Marcel Dekker; 1998. p. 697–707.
4.
go back to reference Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US:1990–1998. Diabetes Care. 2000;23:1278–83.CrossRef Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US:1990–1998. Diabetes Care. 2000;23:1278–83.CrossRef
5.
go back to reference Reaven GM, Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.CrossRef Reaven GM, Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.CrossRef
6.
go back to reference Olefsky JM, Kolterman OG, Scarlett JÁ. Insulin action and resistance in obesity and noninsulin-dependent type 2 diabetes mellitus. Am J Physiol. 1982;243:E15–30.PubMed Olefsky JM, Kolterman OG, Scarlett JÁ. Insulin action and resistance in obesity and noninsulin-dependent type 2 diabetes mellitus. Am J Physiol. 1982;243:E15–30.PubMed
7.
go back to reference Albu J, Raja-Khan N. The management of the obese diabetic patient. Prim Care Clin Office Pract. 2003;30:465–91.CrossRef Albu J, Raja-Khan N. The management of the obese diabetic patient. Prim Care Clin Office Pract. 2003;30:465–91.CrossRef
8.
go back to reference Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus 1986;35:990–8.CrossRef Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus 1986;35:990–8.CrossRef
9.
go back to reference Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef
10.
go back to reference Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev. 2003;(2):CD003641. Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev. 2003;(2):CD003641.
11.
go back to reference Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.CrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.CrossRef
12.
go back to reference Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.CrossRef Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.CrossRef
13.
go back to reference Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.CrossRef Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.CrossRef
14.
go back to reference Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.CrossRef Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.CrossRef
15.
go back to reference Pories WJ, Swanson MS, MacDonald KG, et al. Who would have tought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.CrossRef Pories WJ, Swanson MS, MacDonald KG, et al. Who would have tought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.CrossRef
16.
go back to reference Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg. 1998;227:637–44.CrossRef Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg. 1998;227:637–44.CrossRef
17.
go back to reference Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608–15.CrossRef Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608–15.CrossRef
18.
go back to reference Frezza EE. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg. 2004;14:999–1005.CrossRef Frezza EE. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg. 2004;14:999–1005.CrossRef
19.
go back to reference Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res. 2004;36:747–54.CrossRef Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res. 2004;36:747–54.CrossRef
20.
go back to reference Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide 1 7–36: a physiological incretin in man. Lancet 1987;2:1300–04.CrossRef Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide 1 7–36: a physiological incretin in man. Lancet 1987;2:1300–04.CrossRef
21.
go back to reference Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003;144:5149–58.CrossRef Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003;144:5149–58.CrossRef
22.
go back to reference Patriti A, Facchiano E, Annetti C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1258–64.CrossRef Patriti A, Facchiano E, Annetti C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1258–64.CrossRef
23.
go back to reference Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527–31.CrossRef Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527–31.CrossRef
24.
go back to reference Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.CrossRef Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.CrossRef
25.
go back to reference Estadella D, Oyama LM, Damaso AR, et al. Effect of palatable diet on lipid metabolism of sedentary and exercised rats. Nutrition 2004;20:218–24.CrossRef Estadella D, Oyama LM, Damaso AR, et al. Effect of palatable diet on lipid metabolism of sedentary and exercised rats. Nutrition 2004;20:218–24.CrossRef
26.
go back to reference Vivas LAM, Jamel N, Refinetti RA, et al. Anesthetic experimental device for small animal. Acta Cir Brás. 2007;22(3):229–33.CrossRef Vivas LAM, Jamel N, Refinetti RA, et al. Anesthetic experimental device for small animal. Acta Cir Brás. 2007;22(3):229–33.CrossRef
27.
go back to reference Patriti A, Aisa MC, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose and beta-cell function in Goto-Kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery 2007;142:74–85.CrossRef Patriti A, Aisa MC, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose and beta-cell function in Goto-Kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery 2007;142:74–85.CrossRef
28.
go back to reference Prada PO, Zecchin HG, Torsoni MA, et al. Western diet modulates insulin signaling, c-jun N-terminal kinase activity and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinol 2005;146:1576–87.CrossRef Prada PO, Zecchin HG, Torsoni MA, et al. Western diet modulates insulin signaling, c-jun N-terminal kinase activity and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinol 2005;146:1576–87.CrossRef
29.
go back to reference Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes. Ann Surg. 2004;239:1–11.CrossRef Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes. Ann Surg. 2004;239:1–11.CrossRef
30.
go back to reference Pacheco D, Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto_kakizaki rats. Am J Surg. 2007;194:221–4.CrossRef Pacheco D, Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto_kakizaki rats. Am J Surg. 2007;194:221–4.CrossRef
31.
go back to reference Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223–8.CrossRef Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223–8.CrossRef
Metadata
Title
Glucose Tolerance in the Proximal Versus the Distal Small Bowel in Wistar Rats
Authors
Marcus Vinicius Dantas de Campos Martins
Antônio Augusto Peixoto
Alberto Schanaider
Christiano Costa Esposito
Carolina Barreira Albano Aratanha
Publication date
01-02-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 2/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9651-3

Other articles of this Issue 2/2009

Obesity Surgery 2/2009 Go to the issue